Juan José Reina

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

Eduardo Díaz‐Rubio, Josep Tabernero, Auxiliadora Gómez‐España et al. · Journal of Clinical Oncology · 2007 · 269 citations · Full text

Medicine, Oncology, Pharmacology +11

Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: Comparative outcomes from the 03-TTD-01 phase III study

Javier Sastre, Enrique Aranda, Bartomeu Massutí et al. · Critical Reviews in Oncology/Hematology · 2008 · 50 citations

Medicine, Geriatric Medicine, Oncology +11

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

Jaume Capdevila, José Trigo, Javier Aller et al. · European Journal of Endocrinology · 2017 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis

Jaume Capdevila, Isabel Sevilla, Vicente Alonso et al. · BMC Cancer · 2015 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Oxaliplatin in Combination With Infusional 5-Fluorouracil as First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Phase II Study of the Spanish Cooperative Group for the Treatment of Digestive Tumors

Manuel Benavides, Carles Pericay, Manuel Valladares‐Ayerbes et al. · Clinical Colorectal Cancer · 2012 · 19 citations · Full text

Medicine, Oncology, Pharmacotherapy +11